Radium 223 combined with new hormone therapies for the treatment of castrate-resistant metastatic prostate cancer: scientific evidence and sharing of our experience.

Radium 223 combined with new hormone therapies for the treatment of castrate-resistant metastatic prostate cancer: scientific evidence and sharing of our experience.
Presentation of the attention-grabbing case of a affected person affected by castrate-resistant prostate most cancers (CRPC) with bone metastasis, who obtained concomitant treatment with abiraterone acetate (AA) and radium-223. The affected person skilled important scientific enchancment in his high quality of life and ache aid after starting the aforementioned treatment, with out being affected by opposed toxicities.
Currently, the appropriate choice of sufferers to obtain radium-223 treatment remains to be a scientific problem in the case of CRPC with metastasis. In this text, we talk about the future prospects of this treatment, reviewing present evidence about concomitant therapies with radium-223 and its current state, primarily based upon the current suggestions from the Pharmacovigilance Risk Assessment Committee (PRAC), and the knowledge offered in the ERA-223 examine.
Based on our scientific expertise, we offer sensible orientation for the integration of this radiopharmaceutical in the therapeutic plan for this group of sufferers. We conclude, regardless of some of the constructive outcomes and our wonderful expertise, that it will be clever to attend for the outcomes of the scientific trials which are finding out the security and advantages of the combined use of radium-223 with new hormone therapies.
Bearing in thoughts that to this point, the solely revealed large-scale randomised trial that investigated the mixture of AR-axis-targeted remedy with Ra-223 is unfavourable, the harms of the mixture outweighed any advantages in ERA-223. Nonetheless, with a purpose to advocate whether or not or not this treatment must be used, it’s important to outline the affected person profile that would profit from this therapeutic possibility.
Radium 223 combined with new hormone therapies for the treatment of castrate-resistant metastatic prostate cancer: scientific evidence and sharing of our experience.
Radium 223 combined with new hormone therapies for the treatment of castrate-resistant metastatic prostate most cancers: scientific evidence and sharing of our expertise.

Clinical Response to Apatinib Combined With Brain Radiotherapy in EGFR Wild-Type and ALK-Negative Lung Adenocarcinoma With Multiple Brain Metastases.

Clinical Response to Apatinib Combined With Brain Radiotherapy in EGFR Wild-Type and ALK-Negative Lung Adenocarcinoma With Multiple Brain Metastases.

Background: Brain radiotherapy is the usual remedy possibility for a number of mind metastases (BMs) from non-small cell lung most cancers (NSCLC), particularly in the absence of a driver mutation. However, the prognosis for such sufferers stays poor. Apatinib is a potent antiangiogenic compound directed on the vascular endothelial progress issue receptor-2 (VEGFR-2); nevertheless, to date, there are not any investigations of apatinib concurrent with mind radiotherapy for NSCLC sufferers with BMs.

We report a case of EGFR wild-type and ALK-negative lung adenocarcinoma affected person with a number of symptomatic BMs, who obtained apatinib along with mind radiation remedy. A positive oncologic consequence was achieved for each mind metastatic lesions and the first pulmonary tumor. Case Presentation: A 61-year-old feminine (by no means smoker) who initially offered with headache and dizziness was recognized with lung adenocarcinoma with a number of mind metastasis (cT2aN3M1b stage IV), and was unfavorable for EGFR and ALK.

The affected person refused to obtain chemotherapy and was solely amenable to mind radiotherapy and focused remedy. After approval from the institutional ethics committee, she underwent concurrent oral apatinib (500 mg/day) with complete mind radiation remedy (WBRT) (37.5Gy) with simultaneous in-field increase (49.5Gy) in 15 fractions with picture guided intensity-modulated radiotherapy.

Three weeks later, neurologic signs totally ceased and a partial response (PR) for the BMs with near-complete decision of peritumoral mind edema was achieved. Chest CT carried out on the identical time and confirmed shrinkage of the lung main with a PR.

The affected person suffered grade III oral mucositis one week after mind radiotherapy and refused additional apatinib. At 12 months after mind radiotherapy, the mind tumors remained properly managed. Conclusions: This is the primary identified documentation of a speedy medical response of apatinib concurrent with mind radiotherapy in a lung adenocarcinoma affected person with symptomatic a number of BMs. Apatinib mixed with mind radiotherapy could possibly be another remedy possibility for BMs from NSCLC, particularly for these with no driver mutation. Further medical trials are required to corroborate this discovery.

Clinical Response to Apatinib Combined With Brain Radiotherapy in EGFR Wild-Type and ALK-Negative Lung Adenocarcinoma With Multiple Brain Metastases.
Clinical Response to Apatinib Combined With Brain Radiotherapy in EGFR Wild-Type and ALK-Negative Lung Adenocarcinoma With Multiple Brain Metastases.

Pattern of Pediatric Supracondylar Fracture Operated at A Rural Teaching Hospital of Nepal: A Descriptive Cross-sectional Study.

Supracondylar fracture of humerus is likely one of the frequent pediatric fractures encountered in our every day medical observe. The goal of this examine is to decide the sample of supracondylar fracture operated at rural educating hospital of Jumla, Karnali Nepal.A descriptive cross sectional examine was carried out at Jumla, Karnali after Institutional Review Committee approval.

Operating room notes from 15 May 2017 to 16 November 2019 had been retrieved to collect the next data: sufferers tackle, age, intercourse, aspect, harm mechanism, displacement, neurovascular harm, concurrent accidents, preliminary administration by conventional bone setters, time between harm and surgical procedure, operative method.

NOD2 Antibody

1-CSB-PA446192
  • EUR 317.00
  • EUR 244.00
  • 100ul
  • 50ul
  • Form: Liquid
  • Buffer: -20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol Antigen affinity purification
Description: A polyclonal antibody against NOD2. Recognizes NOD2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200

NOD2 Antibody

DF12125 200ul
EUR 304.00
Description: NOD2 antibody detects endogenous levels of NOD2.

NOD2 Antibody

1-CSB-PA876985
  • EUR 317.00
  • EUR 244.00
  • 100ul
  • 50ul
  • Form: Liquid
  • Buffer: -20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol Antigen affinity purification
Description: A polyclonal antibody against NOD2. Recognizes NOD2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:2000, IHC:1:25-1:100

NOD2 Antibody

1-CSB-PA881021LA01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against NOD2. Recognizes NOD2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200

Nod2 antibody

10R-6553 100 ug
EUR 435.00
Description: Rat monoclonal Nod2 antibody

NOD2 Antibody

24158-100ul 100ul
EUR 390.00

NOD2 Antibody

24159-100ul 100ul
EUR 390.00

NOD2 Antibody

37460-100ul 100ul
EUR 252.00

NOD2 Antibody

1-CSB-PA015915GA01HU
  • EUR 597.00
  • EUR 333.00
  • 150ul
  • 50ul
  • Form: Liquid
  • Buffer: PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3. -20℃, Avoid freeze / thaw cycles. Antigen Affinity purified
Description: A polyclonal antibody against NOD2. Recognizes NOD2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB

anti-NOD2

YF-PA27607 50 ug
EUR 363.00
Description: Mouse polyclonal to NOD2

NOD2 Rabbit pAb

A15992-100ul 100 ul
EUR 308.00

NOD2 Rabbit pAb

A15992-200ul 200 ul
EUR 459.00

NOD2 Rabbit pAb

A15992-20ul 20 ul
EUR 183.00

NOD2 Rabbit pAb

A15992-50ul 50 ul
EUR 223.00

NOD2 Blocking Peptide

DF12125-BP 1mg
EUR 195.00

Polyclonal NOD2 Antibody

APR06297G 0.1 mg
EUR 659.00
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD2 . This antibody is tested and proven to work in the following applications:

Polyclonal NOD2 Antibody

APR06298G 0.1 mg
EUR 659.00
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD2 . This antibody is tested and proven to work in the following applications:

NOD2 Conjugated Antibody

C37460 100ul
EUR 397.00

Anti-NOD2 antibody

PAab05781 100 ug
EUR 412.00

Anti-NOD2 antibody

STJ118451 100 µl
EUR 277.00

Human NOD2 shRNA Plasmid

20-abx961935
  • EUR 801.00
  • EUR 1121.00
  • 150 µg
  • 300 µg
  • Shipped within 15-20 working days.

Anti-NOD2 (Card15) Antibody

A00087 50 ul
EUR 397.00
Description: Rabbit Polyclonal NOD2 (Card15) Antibody. Validated in IP, IHC, WB and tested in Human.

NOD2 Antibody, HRP conjugated

1-CSB-PA881021LB01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against NOD2. Recognizes NOD2 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

NOD2 Antibody, FITC conjugated

1-CSB-PA881021LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against NOD2. Recognizes NOD2 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

NOD2 Antibody, Biotin conjugated

1-CSB-PA881021LD01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against NOD2. Recognizes NOD2 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

NOD2 ELISA KIT|Human

EF001273 96 Tests
EUR 689.00

Mouse Nod2 ELISA KIT

ELI-44123m 96 Tests
EUR 865.00

Bovine NOD2 ELISA KIT

ELI-22273b 96 Tests
EUR 928.00

Human NOD2 ELISA KIT

ELI-23582h 96 Tests
EUR 824.00

TLR2 & NOD2-Based Adjuvant

VAdv-Ly0016 5 mg
EUR 3347.00
Description: A TLR2 & NOD2-based vaccine adjuvant.

NOD2 ORF Vector (Human) (pORF)

ORF026166 1.0 ug DNA
EUR 405.00

Nod2 ORF Vector (Rat) (pORF)

ORF071395 1.0 ug DNA
EUR 506.00

Nod2 ORF Vector (Mouse) (pORF)

ORF051499 1.0 ug DNA
EUR 506.00

h NOD2 inducible lentiviral particles

LVP627 1x107 IFU/ml x 200ul
EUR 451.00
Description: Pre-made over-expression lentivirus for expressing human target: NOD2 (nucleotide-binding oligomerization domain containing 2), [alternative names: ACUG; BLAU; CARD15; CD; CLR16.3; IBD1; NLRC2; NOD2B; PSORAS1]. The sub-cloned codon sequence is identical (100% match) to CDS region in NCBI ID: NM_022162.1. It also contains a RFP-Blasticidin dual selection marker.

pECMV-Nod2-m-FLAG Plasmid

PVT15371 2 ug
EUR 325.00

Anti-CARD15 / NOD2 (Internal) antibody

STJ70992 100 µg
EUR 359.00

Polyclonal NOD2 / CARD15 Antibody (N-Terminus)

APR02524G 0.05mg
EUR 484.00
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD2 / CARD15 (N-Terminus). This antibody is tested and proven to work in the following applications:

Polyclonal NOD2 / CARD15 Antibody (C-Terminus)

APR02525G 0.05mg
EUR 484.00
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD2 / CARD15 (C-Terminus). This antibody is tested and proven to work in the following applications:

NOD2 sgRNA CRISPR Lentivector set (Human)

K1438601 3 x 1.0 ug
EUR 339.00

Nod2 sgRNA CRISPR Lentivector set (Mouse)

K4411601 3 x 1.0 ug
EUR 339.00

Nod2 sgRNA CRISPR Lentivector set (Rat)

K6718501 3 x 1.0 ug
EUR 339.00

Polyclonal Goat Anti-CARD15 / NOD2 (Internal) Antibody

APG00059G 0.1mg
EUR 484.00
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-CARD15 / NOD2 (Internal) . This antibody is tested and proven to work in the following applications:

NOD2 Protein Vector (Human) (pPB-C-His)

PV104662 500 ng
EUR 811.00

NOD2 Protein Vector (Human) (pPB-N-His)

PV104663 500 ng
EUR 811.00

NOD2 Protein Vector (Human) (pPM-C-HA)

PV104664 500 ng
EUR 811.00

NOD2 Protein Vector (Human) (pPM-C-His)

PV104665 500 ng
EUR 811.00

NOD2 sgRNA CRISPR Lentivector (Human) (Target 1)

K1438602 1.0 ug DNA
EUR 154.00

NOD2 sgRNA CRISPR Lentivector (Human) (Target 2)

K1438603 1.0 ug DNA
EUR 154.00

NOD2 sgRNA CRISPR Lentivector (Human) (Target 3)

K1438604 1.0 ug DNA
EUR 154.00

Nod2 sgRNA CRISPR Lentivector (Mouse) (Target 1)

K4411602 1.0 ug DNA
EUR 154.00

Nod2 sgRNA CRISPR Lentivector (Mouse) (Target 2)

K4411603 1.0 ug DNA
EUR 154.00

Nod2 sgRNA CRISPR Lentivector (Mouse) (Target 3)

K4411604 1.0 ug DNA
EUR 154.00

Nod2 sgRNA CRISPR Lentivector (Rat) (Target 1)

K6718502 1.0 ug DNA
EUR 154.00

Nod2 sgRNA CRISPR Lentivector (Rat) (Target 2)

K6718503 1.0 ug DNA
EUR 154.00

Nod2 sgRNA CRISPR Lentivector (Rat) (Target 3)

K6718504 1.0 ug DNA
EUR 154.00

NOD2 3'UTR Luciferase Stable Cell Line

TU015801 1.0 ml
EUR 1364.00

NOD2 3'UTR GFP Stable Cell Line

TU065801 1.0 ml
EUR 1364.00

NOD2 Protein Vector (Mouse) (pPB-C-His)

PV205994 500 ng
EUR 1065.00

NOD2 Protein Vector (Mouse) (pPB-N-His)

PV205995 500 ng
EUR 1065.00

NOD2 Protein Vector (Mouse) (pPM-C-HA)

PV205996 500 ng
EUR 1065.00

NOD2 Protein Vector (Mouse) (pPM-C-His)

PV205997 500 ng
EUR 1065.00

NOD2 Protein Vector (Rat) (pPB-C-His)

PV285578 500 ng
EUR 1166.00

NOD2 Protein Vector (Rat) (pPB-N-His)

PV285579 500 ng
EUR 1166.00

NOD2 Protein Vector (Rat) (pPM-C-HA)

PV285580 500 ng
EUR 1166.00

NOD2 Protein Vector (Rat) (pPM-C-His)

PV285581 500 ng
EUR 1166.00

Nod2 3'UTR GFP Stable Cell Line

TU164191 1.0 ml Ask for price

Nod2 3'UTR GFP Stable Cell Line

TU264065 1.0 ml Ask for price

Nod2 3'UTR Luciferase Stable Cell Line

TU214065 1.0 ml Ask for price

Nod2 3'UTR Luciferase Stable Cell Line

TU114191 1.0 ml Ask for price

Nucleotide Binding Oligomerization Domain Containing 2 (NOD2) Antibody

abx235781-100ug 100 ug
EUR 551.00
  • Shipped within 5-12 working days.

Nucleotide Binding Oligomerization Domain Containing 2 (NOD2) Antibody

20-abx302321
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug
  • Shipped within 5-10 working days.

Nucleotide Binding Oligomerization Domain Containing 2 (NOD2) Antibody

20-abx114240
  • EUR 732.00
  • EUR 398.00
  • 150 ul
  • 50 ul
  • Shipped within 5-10 working days.

NOD2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV645601 1.0 ug DNA
EUR 1355.00

NOD2 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV645605 1.0 ug DNA
EUR 1355.00

NOD2 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV645606 1.0 ug DNA
EUR 1355.00

Nucleotide Binding Oligomerization Domain Containing 2 (NOD2) Antibody (HRP)

20-abx316579
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug
  • Shipped within 5-10 working days.

Nucleotide Binding Oligomerization Domain Containing 2 (NOD2) Antibody (FITC)

20-abx316580
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug
  • Shipped within 5-10 working days.

Nucleotide Binding Oligomerization Domain Containing 2 (NOD2) Antibody (Biotin)

20-abx316581
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug
  • Shipped within 5-10 working days.

Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) Antibody

20-abx339338
  • EUR 411.00
  • EUR 300.00
  • 100 ul
  • 50 ul
  • Shipped within 5-10 working days.

Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) Antibody

20-abx211027
  • EUR 411.00
  • EUR 300.00
  • 100 ul
  • 50 ul
  • Shipped within 5-10 working days.

NOD2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

K1438605 3 x 1.0 ug
EUR 376.00

Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)

K4411605 3 x 1.0 ug
EUR 376.00

Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)

K6718505 3 x 1.0 ug
EUR 376.00

Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) ELISA Kit

20-abx258642
  • EUR 7378.00
  • EUR 3933.00
  • EUR 911.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests
  • Shipped within 5-7 working days.

Human Nucleotide-binding oligomerization domain-containing protein 2(NOD2) ELISA kit

CSB-EL015915HU-24T 1 plate of 24 wells
EUR 165.00
  • Sample volume: 50-100ul
  • Detection wavelength: 450nm
  • Assay performance time: 1 to 4 hours.
Description: Quantitativesandwich ELISA kit for measuring Human Nucleotide-binding oligomerization domain-containing protein 2 (NOD2) in samples from serum, plasma, asciticfluid, tissue homogenates, cell lysates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Human Nucleotide-binding oligomerization domain-containing protein 2(NOD2) ELISA kit

1-CSB-EL015915HU
  • EUR 804.00
  • EUR 5099.00
  • EUR 2704.00
  • 1 plate of 96 wells
  • 10 plates of 96 wells each
  • 5 plates of 96 wells each
  • Sample volume: 50-100ul
  • Detection wavelength: 450nm
  • Assay performance time: 1 to 4 hours.
Description: Quantitativesandwich ELISA kit for measuring Human Nucleotide-binding oligomerization domain-containing protein 2(NOD2) in samples from serum, plasma, asciticfluid, tissue homogenates, cell lysates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) CLIA Kit

20-abx190892
  • EUR 7911.00
  • EUR 4215.00
  • EUR 973.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests
  • Shipped within 5-7 working days.

NOD2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)

K1438606 1.0 ug DNA
EUR 167.00

NOD2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)

K1438607 1.0 ug DNA
EUR 167.00

NOD2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)

K1438608 1.0 ug DNA
EUR 167.00

NOD2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV645602 1.0 ug DNA
EUR 1355.00

NOD2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV645603 1.0 ug DNA
EUR 1413.00

NOD2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV645604 1.0 ug DNA
EUR 1413.00

Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)

K4411606 1.0 ug DNA
EUR 167.00

Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)

K4411607 1.0 ug DNA
EUR 167.00

Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3)

K4411608 1.0 ug DNA
EUR 167.00

Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)

K6718506 1.0 ug DNA
EUR 167.00

Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)

K6718507 1.0 ug DNA
EUR 167.00

Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)

K6718508 1.0 ug DNA
EUR 167.00

Human Nucleotide Binding Oligomerization Domain Containing Protein 2 ELISA Kit (NOD2)

RK01942 96 Tests
EUR 521.00

Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2)CLIA Kit

SCK295Hu-10x96wellstestplate 10x96-wells test plate
EUR 5647.80
  • The Intra-assay Precision is determined when 3 samples with low, middle and high level of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) were tested on 3 different plates, 8 replicates in each plate
  • CV(%) = SD/meanX100
  • Show more
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in Tissue homogenates, cell lysates and other biological fluids.

Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2)CLIA Kit

SCK295Hu-1x48wellstestplate 1x48-wells test plate
EUR 552.76
  • The Intra-assay Precision is determined when 3 samples with low, middle and high level of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) were tested on 3 different plates, 8 replicates in each plate
  • CV(%) = SD/meanX100
  • Show more
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in Tissue homogenates, cell lysates and other biological fluids.

Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2)CLIA Kit

SCK295Hu-1x96wellstestplate 1x96-wells test plate
EUR 746.80
  • The Intra-assay Precision is determined when 3 samples with low, middle and high level of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) were tested on 3 different plates, 8 replicates in each plate
  • CV(%) = SD/meanX100
  • Show more
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in Tissue homogenates, cell lysates and other biological fluids.

Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2)CLIA Kit

SCK295Hu-5x96wellstestplate 5x96-wells test plate
EUR 3060.60
  • The Intra-assay Precision is determined when 3 samples with low, middle and high level of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) were tested on 3 different plates, 8 replicates in each plate
  • CV(%) = SD/meanX100
  • Show more
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in Tissue homogenates, cell lysates and other biological fluids.

Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) CLIA Kit

4-SCK295Hu
  • EUR 5698.00
  • EUR 3061.00
  • EUR 747.00
  • 10 plates of 96 wells
  • 5 plates of 96 wells
  • 1 plate of 96 wells
  • Known also as Nucleotide Binding Oligomerization Domain Containing Protein 2 Clia kit. Alternative names of the recognized antigen: CD
  • ACUG
  • BLAU
  • CARD15
  • CLR16.3
  • IBD1
  • NLRC2
  • NOD2B
  • PSORAS1
  • Caspase recruitment domain-containing protein 15
  • Inflam
  • Show more
Description: Double-antibody Sandwich chemiluminescent immunoassay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2)Tissue homogenates, cell lysates and other biological fluids

Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) ELISA Kit

SEK295Hu-10x96wellstestplate 10x96-wells test plate
EUR 4731.50
  • The Intra-assay Precision is determined when 3 samples with low, middle and high level of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) were tested on 3 different plates, 8 replicates in each plate
  • CV(%) = SD/meanX100
  • Show more
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in tissue homogenates, cell lysates and other biological fluids.

Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) ELISA Kit

SEK295Hu-1x48wellstestplate 1x48-wells test plate
EUR 477.30
  • The Intra-assay Precision is determined when 3 samples with low, middle and high level of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) were tested on 3 different plates, 8 replicates in each plate
  • CV(%) = SD/meanX100
  • Show more
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in tissue homogenates, cell lysates and other biological fluids.

Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) ELISA Kit

SEK295Hu-1x96wellstestplate 1x96-wells test plate
EUR 639.00
  • The Intra-assay Precision is determined when 3 samples with low, middle and high level of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) were tested on 3 different plates, 8 replicates in each plate
  • CV(%) = SD/meanX100
  • Show more
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in tissue homogenates, cell lysates and other biological fluids.

Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) ELISA Kit

SEK295Hu-5x96wellstestplate 5x96-wells test plate
EUR 2575.50
  • The Intra-assay Precision is determined when 3 samples with low, middle and high level of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) were tested on 3 different plates, 8 replicates in each plate
  • CV(%) = SD/meanX100
  • Show more
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in tissue homogenates, cell lysates and other biological fluids.

Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) ELISA Kit

4-SEK295Hu
  • EUR 4782.00
  • EUR 2526.00
  • EUR 640.00
  • 10 plates of 96 wells
  • 5 plates of 96 wells
  • 1 plate of 96 wells
  • Known also as Nucleotide Binding Oligomerization Domain Containing Protein 2 elisa. Alternative names of the recognized antigen: CD
  • ACUG
  • BLAU
  • CARD15
  • CLR16.3
  • IBD1
  • NLRC2
  • NOD2B
  • PSORAS1
  • Caspase recruitment domain-containing protein 15
  • Inflammat
  • Show more
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in samples from tissue homogenates, cell lysates and other biological fluids with no significant corss-reactivity with analogues from other species.

ELISA kit for Human NOD2 (Nucleotide Binding Oligomerization Domain Containing Protein 2)

ELK5352 1 plate of 96 wells
EUR 432.00
  • The microtiter plate provided in this kit has been pre-coated with an antibody specific to Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2). Standards or samples are then added to the appropriate microtiter plate wells with a bio
  • Show more
Description: A sandwich ELISA kit for detection of Nucleotide Binding Oligomerization Domain Containing Protein 2 from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids.

Data evaluation was performed utilizing Statistical Package for Social Sciences model 20.Left aspect predominated with 88 (63.7%) and extension kind was frequent in 135 (97.8%). Thirteen (9.4%) sufferers had been initially managed by conventional bonesetters. A complete of 138 kids underwent operative fixation with imply age of seven.47 years and gender ratio of two:1 boy to woman.

Fall from cliff, ladders and rooftops had been the prevailing explanation for harm 73 (52.8%). Average time between harm and surgical procedure was 5.2 days. Closed discount was performed in 100 (72.4%) sufferers whereas open discount was crucial in 38 (27.5%) sufferers.Closed extension kind pediatric supracondylar fracture was frequent in this examine. Fall from cliff, rooftop and ladder are the most important explanation for fracture. Delayed presentation and preliminary administration of the fracture by the standard bonesetters makes supracondylar fracture tougher in useful resource restricted setting like ours.